Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden
Int J Hematol
.
2017 Jan;105(1):109-110.
doi: 10.1007/s12185-016-2155-3.
Authors
Tadahiko Igarashi
1
,
Michinori Ogura
2
3
,
Kuniaki Itoh
4
,
Masafumi Taniwaki
5
,
Kiyoshi Ando
6
,
Yoshiaki Kuroda
7
8
,
Kazuhito Yamamoto
9
,
Naokuni Uike
10
11
,
Akihiro Tomita
12
13
,
Hirokazu Nagai
14
,
Mitsutoshi Kurosawa
15
,
Shigeo Mori
16
,
Shigeru Nawano
17
,
Takashi Terauchi
18
19
,
Yasuo Ohashi
20
,
Kensei Tobinai
21
Affiliations
1
Division of Hematology/Oncology, Gunma Cancer Center, 617-1 Takabayashinishicho, Ohta, 373-8550, Japan. taigarash@gunma-cc.jp.
2
Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
3
Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan.
4
Department of Hematology, National Cancer Center Hospital East, Chiba, Japan.
5
Department of Hematology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
6
Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan.
7
Department of Hematology, Hiroshima University School of Medicine, Hiroshima, Japan.
8
Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
9
Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
10
Department of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.
11
Department of Palliative Care, Saga Prefectural Hospital Koseikan, Saga, Japan.
12
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
13
Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
14
Department of Hematology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.
15
Department of Hematology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.
16
The University of Tokyo, Tokyo, Japan.
17
Department of Radiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
18
Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
19
Department of Nuclear Medicine, Cancer Institute Hospital, Tokyo, Japan.
20
Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
21
Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
PMID:
27896571
DOI:
10.1007/s12185-016-2155-3
No abstract available
Publication types
Published Erratum